Drug Approval | September 28, 2022
EDQM grants CEP certificate to Supriya Lifescience for Diphenhydramine Hydrochloride
This will be an added advantage for Supriya Lifescience Limited in the European market.
This will be an added advantage for Supriya Lifescience Limited in the European market.
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine
The second day of Arogya Manthan 2022 had panel discussions with eminent thought leaders from relevant public and private sector organizations
India's healthcare system has shown great efficiency not only in providing diagnostic and management facilities but also in minimizing mortality and maximizing recovery
The committee unanimously decided to confer the Lifetime Achievement Award to Kiran Mazumdar-Shaw for her monumental contributions as a global leader in biotechnology innovation and entrepreneurship
The #Heart2HeartChallengeIndia campaign is very simple – you have to climb 60 steps in a minute, make a video of it, share it on your social media, tag 5 people, inviting them to take this challenge to check their heart health
AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
To set up 50 lifestyle modification centres across the UAE in the next 24 months
Subscribe To Our Newsletter & Stay Updated
